Related Experiment Video
Updated: Dec 9, 2025

Probing Myosin Ensemble Mechanics in Actin Filament Bundles Using Optical Tweezers
Published on: May 4, 2022
Novel blood coagulation molecules: Skeletal muscle myosin and cardiac myosin
Hiroshi Deguchi1, Shravan Morla1, John H Griffin1,2
1Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.
Insights
Striated muscle myosins, skeletal muscle myosin (SkM) and cardiac myosin (CM), regulate blood clotting by promoting thrombin generation and factor Va inactivation. These myosins show potential roles in hemostasis and thrombosis.
Area of Science:
- Biochemistry
- Hematology
- Cardiovascular Biology
Background:
- Striated muscle myosins, skeletal muscle myosin (SkM) and cardiac myosin (CM), are motor proteins.
- Thrombin generation is crucial for hemostasis and thrombosis, typically requiring specific surfaces like phosphatidylserine.
- Activated protein C (APC) regulates coagulation by inactivating factor Va, a process usually dependent on protein S.
Purpose of the Study:
- To investigate the potential roles of SkM and CM in regulating thrombosis and hemostasis.
- To determine if SkM and CM can provide surfaces for thrombin generation and factor Va inactivation.
- To explore the physiological significance and potential clinical relevance of SkM and CM in hemostasis and thrombosis.
Main Methods:
- Investigated thrombin generation using SkM and CM as surfaces for the prothrombinase complex.
- Assessed the ability of SkM and CM to support factor Va inactivation by APC/protein S.
- Utilized murine tail cut bleeding and myocardial ischemia-reperfusion injury models to evaluate in vivo hemostatic and injury-exacerbating effects.
- Analyzed human plasma SkM isoforms and their phenotypes.
Main Results:
- SkM and CM can provide surfaces for thrombin generation by the prothrombinase complex without lipids.
- SkM and CM support factor Va inactivation by APC/protein S, downregulating thrombin generation.
- In mice, infused SkM and CM reduce bleeding, while infused CM exacerbates myocardial injury.
- Human plasma SkM isoforms exist in three phenotypes, with one linked to pulmonary embolism.
Conclusions:
- Striated muscle myosins (SkM and CM) actively participate in regulating hemostasis and thrombosis.
- These myosins offer novel pro- and anti-thrombotic surface activities.
- SkM and CM have potential as diagnostic markers and therapeutic targets in thrombotic disorders.
Abstract:
Essentials Striated muscle myosins can promote prothrombin activation by FXa or FVa inactivation by APC. Cardiac myosin and skeletal muscle myosin are pro-hemostatic in murine tail cut bleeding models. Infused cardiac myosin exacerbates myocardial injury caused by myocardial ischemia reperfusion. Skeletal muscle myosin isoforms that circulate in human plasma can be grouped into 3 phenotypes. ABSTRACT: Two striated muscle myosins, namely skeletal muscle myosin (SkM) and cardiac myosin (CM), may potentially contribute to physiologic mechanisms for regulation of thrombosis and hemostasis. Thrombin is generated from activation of prothrombin by the prothrombinase (IIase) complex comprising factor Xa, factor Va, and Ca++ ions located on surfaces where these factors are assembled. We discovered that SkM and CM, which are abundant motor proteins in skeletal and cardiac muscles, can provide a surface for thrombin generation by the prothrombinase complex without any apparent requirement for phosphatidylserine or lipids. These myosins can also provide a surface that supports the inactivation of factor Va by activated protein C/protein S, resulting in negative feedback downregulation of thrombin generation. Although the physiologic significance of these reactions remains to be established for humans, substantive insights may be gleaned from murine studies. In mice, exogenously infused SkM and CM can promote hemostasis as they are capable of reducing tail cut bleeding. In a murine myocardial ischemia-reperfusion injury model, exogenously infused CM exacerbates myocardial infarction damage. Studies of human plasmas show that SkM antigen isoforms of different MWs circulate in human plasma, and they can be used to identify three plasma SkM phenotypes. A pilot clinical study showed that one SkM isoform pattern appeared to be linked to isolated pulmonary embolism. These discoveries enable multiple preclinical and clinical studies of SkM and CM, which should provide novel mechanistic insights with potential translational relevance for the roles of CM and SkM in the pathobiology of hemostasis and thrombosis.
Related Concept Videos
Actin and Myosin in Muscle Contraction
Overview of Myosin Structure and Function
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The Sarcomere
Each...
Clot Retraction and Fibrinolysis
The Role of Actin and Myosin in Non-muscle Cells

